Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375960 · ClinicalTrials.gov registry record · Phase 2
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
A Phase 2 study, sponsored by Vernalis (R&D).
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00375960 is a Phase 2 study that has completed, run by Vernalis (R&D). The registered enrollment target is 50 participants.
The verdict
NCT00375960, a Phase 2 study, has completed, sponsored by Vernalis (R&D).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the safety and efficacy of an investigational drug, V3381, for the treatment of diabetic peripheral neuropathic (DPN) pain (pain in one's feet and legs, or even in one's hands and arms, sometimes experienced by people with diabetes). An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA) and/or Health Canada.
Interventions
- DRUG Placebo
- DRUG V3381
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00375960
The ClinicalTrials.gov registry entry for NCT00375960 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vernalis (R&D), which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00375960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00375960 about?
NCT00375960 is a clinical study titled "A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain". The objective of this study is to investigate the safety and efficacy of an investigational drug, V3381, for the treatment of diabetic peripheral neuropathic (DPN) pain (pain in one's feet and legs, or even in one's hands and arms, sometimes experienced by people with diabetes). An investigational d...
What is the current status of trial NCT00375960?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2006-06. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00375960?
The interventions under investigation include: Placebo (DRUG), V3381 (DRUG).
Who is sponsoring clinical trial NCT00375960?
This trial is sponsored by Vernalis (R&D), which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.